BackMonte Rosa Therapeutics Overview
Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics Target Price

Analysts' 12-month price predictions for GLUE.

Get informed when a big investor buys or sells

+ Follow

Share Price

$23.46

Average Target Price

$35.0049.2% upside

1 analysts in the last 4 months

High: $35 | Low: $35

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-30Guggenheim$3549.2% upsideOpen
2026-01-14Piper Sandler$3757.7% upsideOpen
2026-01-07Jefferies$3132.1% upsideOpen
2026-01-07Wedbush$3757.7% upsideOpen
2025-12-17JefferiesKelly Shi$226.2% downsideOpen
2025-12-16Wells Fargo$226.2% downsideOpen